TScan Therapeutics
TCRX
TCRX
89 hedge funds and large institutions have $126M invested in TScan Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 16 closing their positions.
Holders
89
Holders Change
–
Holders Change %
0%
% of All Funds
1.19%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
31
Reduced
15
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CC
1
Checkpoint Capital
San Francisco,
California
|
$5.34M |
| 2 |
2
Aberdeen Group
Edinburgh,
United Kingdom
|
$2.69M |
| 3 |
3
BlackRock
New York
|
$15.1M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$851K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$434K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Macquarie Group
Sydney, NSW 2000,
Australia
| – | – | -1,047 | Closed |
|
|
GI
102
GAMMA Investing
Foster City,
California
| – | – | -142 | Closed |
|
|
CAL
103
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | – | -2 | Closed |
|
104
Lazard Asset Management
New York
| $0 | 70 | – | – |
|
|
BFP
105
Briaud Financial Planning
College Station,
Texas
| – | – | – | – |
|
|
CFGS
106
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
107
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 16 | +9 | +129% |
|